Literature DB >> 9753275

Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and in Crohn's disease.

F Arai1, T Takahashi, K Furukawa, K Matsushima, H Asakura.   

Abstract

To elucidate the possible role of proinflammatory cytokines in inflammatory bowel disease, the expression and localization of interleukin (IL) -6 and IL-8 mRNAs were examined in colonic biopsy specimens obtained from 10 patients with active ulcerative colitis (UC), 5 with inactive UC, 6 with Crohn's disease (CD), and 5 normal controls. In situ hybridization with digoxigenin-labeled probes and immunohistochemistry for both cytokines were performed. The IL-6 mRNA expression was enhanced in the inflamed mucosa in 4 of 6 CD patients, while that of UC patients stayed at baseline. In contrast, IL-8 mRNA expression was apparently augmented (P = 0.044) in 7 of 10 active UC and 3 of 6 CD patients (NS). The cell count positive for IL-8 mRNA per unit area was definitely increased in moderate/severe UC when compared to mild UC (53.1 +/- 14.4/mm2 vs 9.0 +/- 5.1/mm2, P = 0.028) according to the degree of inflammation. IL-6 mRNA positive cells in CD were preferentially located in deeper lamina propria than IL-8 mRNA positive cells in UC. Interestingly, IL-8 mRNA was expressed in the mucosal epithelial cells in one UC patient. The patients treated by corticosteroids tended to show suppressed expression of each mRNA, except one patient with intractable UC. Our data suggest enhanced expression of mucosal IL-6 mRNA in CD and of IL-8 mRNA in UC by infiltrating mononuclear cells, indicating the distinct participation of each cytokine in the pathogenesis of UC and CD. Moreover, intestinal epithelial cells in UC occasionally exhibit IL-8 mRNA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9753275     DOI: 10.1023/a:1018815432504

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  34 in total

Review 1.  Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes.

Authors:  P Brandtzaeg; T S Halstensen; K Kett; P Krajci; D Kvale; T O Rognum; H Scott; L M Sollid
Journal:  Gastroenterology       Date:  1989-12       Impact factor: 22.682

2.  The value of rectal biopsy in the diagnosis of ulcerative colitis.

Authors:  S G MATTS
Journal:  Q J Med       Date:  1961-10

Review 3.  Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF.

Authors:  K Matsushima; J J Oppenheim
Journal:  Cytokine       Date:  1989-11       Impact factor: 3.861

Review 4.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

5.  Regulation of interleukin-8 production in a human colon epithelial cell line (HT-29).

Authors:  V Gross; T Andus; R Daig; E Aschenbrenner; J Schölmerich; W Falk
Journal:  Gastroenterology       Date:  1995-03       Impact factor: 22.682

6.  Relationship of functional and antigenic interleukin 6 to disease activity in inflammatory bowel disease.

Authors:  J S Hyams; J E Fitzgerald; W R Treem; N Wyzga; D L Kreutzer
Journal:  Gastroenterology       Date:  1993-05       Impact factor: 22.682

7.  Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation.

Authors:  L Mazzucchelli; C Hauser; K Zgraggen; H Wagner; M Hess; J A Laissue; C Mueller
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

8.  Significance of interleukin 6 in patients with sarcoidosis.

Authors:  K Sahashi; Y Ina; K Takada; T Sato; M Yamamoto; M Morishita
Journal:  Chest       Date:  1994-07       Impact factor: 9.410

9.  Immune activation genes in inflammatory bowel disease.

Authors:  T Matsuura; G A West; K R Youngman; J S Klein; C Fiocchi
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

10.  GM-CSF, IL-1 alpha, IL-1 beta, IL-6, IL-8, IL-10, ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with lipopolysaccharide, IL-1 alpha and TNF-alpha.

Authors:  G Pang; L Couch; R Batey; R Clancy; A Cripps
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

View more
  16 in total

1.  Elevated urinary cytokine levels in patients undergoing ileal neobladder replacement compared with sigmoid neobladder replacement.

Authors:  Yuzo Nakano; Hideaki Miyake; Taka-Aki Inoue; Atsushi Takenaka; Isao Hara; Masato Fujisawa
Journal:  Int Urol Nephrol       Date:  2007-02-20       Impact factor: 2.370

2.  Chios mastic treatment of patients with active Crohn's disease.

Authors:  Andriana C Kaliora; Maria G Stathopoulou; John K Triantafillidis; George V Z Dedoussis; Nikolaos K Andrikopoulos
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

3.  Crohn's disease as an immunodeficiency.

Authors:  Bu'Hussain Hayee; Farooq Z Rahman; Gavin Sewell; Andrew M Smith; Anthony W Segal
Journal:  Expert Rev Clin Immunol       Date:  2010-07       Impact factor: 4.473

4.  Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients.

Authors:  Krishna P Reddy; Jonathan E Markowitz; Eduardo D Ruchelli; Robert N Baldassano; Kurt A Brown
Journal:  Dig Dis Sci       Date:  2007-01-12       Impact factor: 3.199

Review 5.  Chemokines in the inflammatory bowel diseases.

Authors:  R P MacDermott
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

Review 6.  Clinical studies in patients with Castleman's disease, Crohn's disease, and rheumatoid arthritis in Japan.

Authors:  Norihiro Nishimoto
Journal:  Clin Rev Allergy Immunol       Date:  2005-06       Impact factor: 8.667

7.  Lidocaine inhibits secretion of IL-8 and IL-1beta and stimulates secretion of IL-1 receptor antagonist by epithelial cells.

Authors:  M Lahav; M Levite; L Bassani; A Lang; H Fidder; R Tal; S Bar-Meir; L Mayer; Y Chowers
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

8.  Endoscopic findings can predict the efficacy of leukocytapheresis for steroid-naive patients with moderately active ulcerative colitis.

Authors:  Yasushi Umehara; Masatoshi Kudo; Masanori Kawasaki
Journal:  World J Gastroenterol       Date:  2008-09-14       Impact factor: 5.742

9.  Alterations in the function of circulating mononuclear cells derived from patients with Crohn's disease treated with mastic.

Authors:  Andriana-C Kaliora; Maria-G Stathopoulou; John-K Triantafillidis; George-Vz Dedoussis; Nikolaos-K Andrikopoulos
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

Review 10.  Recent advances in basic and clinical aspects of inflammatory bowel disease: which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease?

Authors:  Hitoshi Asakura; Kenji Suzuki; Terasu Honma
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.